Nant Capital, LLC and Dr. Patrick Soon-Shiong filed a Schedule 13D with the SEC on November 4, 2026, disclosing a beneficial ownership position of 19.99% in Peraso Inc. following a private placement that closed on or around October 28, 2026.

Key Highlights

  • Aggregate beneficial ownership: Nant Capital and Dr. Patrick Soon-Shiong each report 4,088,683 shares beneficially owned, representing 19.99% of Peraso Inc. common stock outstanding.
  • PIPE aggregate purchase price: The Purchaser paid $9,999,999.72 at closing, funded from Nant Capital's working capital, according to the filing.
  • Securities acquired: The Purchaser received 3,271,355 shares of common stock, 16,593,563 Pre-Funded Warrants, and 19,864,918 Common Warrants at closing.
  • Pricing: The price per share of common stock and accompanying Common Warrant was $0.5034; the price per Pre-Funded Warrant and accompanying Common Warrant was $0.5024.
  • Board designation rights: Under the Purchase Agreement, the Purchaser may designate two board members while owning 16.7% or more, and one board member while owning 5% or more, of Peraso's outstanding common stock.
  • Shares outstanding basis: The beneficial ownership percentage is calculated on 19,636,317 shares of common stock outstanding as of October 28, 2026, per the filing.
  • Blocker provision: The Warrants contain a 19.99% beneficial ownership exercise limitation; 35,641,153 shares underlying the Warrants are not exercisable within 60 days of the filing date as a result.

Nant Capital and Soon-Shiong Disclose Peraso PIPE Transaction Details

According to the Schedule 13D filed jointly by Nant Capital, LLC and Dr. Patrick Soon-Shiong, the two reporting persons participated in a private investment in public equity (PIPE) transaction with Peraso Inc. (NASDAQ:PRSO), a San Jose, California company whose common stock carries a par value of $0.001 per share. The Purchase Agreement was entered into on October 26, 2026, with the triggering event date listed as October 28, 2026. Dr. Soon-Shiong is disclosed as the sole member of Nant Capital, LLC, a Delaware limited liability company whose principal business is "investment in, and the acquisition and holding of securities and other assets," according to the filing.

The filing states that the aggregate purchase price of $9,999,999.72 was funded from Nant Capital's working capital. The Warrants received in the transaction include a Blocker restricting exercise where doing so would cause beneficial ownership to exceed 19.99% of outstanding shares. As of the filing date, the Reporting Persons disclaim beneficial ownership of 35,641,153 shares underlying the Warrants that are not exercisable within 60 days, while 817,328 shares subject to Warrants are exercisable within that window and are included in the reported 4,088,683 aggregate beneficial ownership figure.

The filing discloses that the securities were "acquired for investment purposes." Under the terms of the Purchase Agreement, so long as ownership remains at or above 16.7%, the Purchaser may designate two individuals for appointment to Peraso's board of directors, one of whom shall be Dr. Soon-Shiong "so long as the Reporting Person is reasonably available." These board designation rights are described in the filing as "personal to the Purchaser and may not be assigned." The filing also notes the Purchaser may engage in discussions with Peraso's board, management, or other stockholders regarding the company's business, operations, governance, or capitalization.

What Was Disclosed

Nant Capital, LLC and Dr. Patrick Soon-Shiong filed a Schedule 13D disclosing a 19.99% beneficial ownership stake in Peraso Inc. following a $9,999,999.72 PIPE transaction, including shares, Pre-Funded Warrants, and Common Warrants, with associated board designation rights.